Applications in progress
Secondary Data Analysis Projects (SDAP 2025)
The Secondary Data Analysis Projects (SDAP) are designed to bring together researchers, knowledge users and data controllers to develop research projects that answer policy and/or practice-relevant questions by using secondary data.
The HRB hosted an in-person SDAP Seminar on 26 March 2025. Slides from the event are available on the call web page, which also includes a summary of the event.
The SDAP 2025 Scheme has two separate application cycles. Cycle 1 has been completed with 6 applications recommended for funding.
Cycle 2 opened for applications on 1 September 2025 and closed on 9 January 2026 at 13:00. The scheme has been extremely competitive. Peer and public reviews have been completed. All applicants have been informed of the outcome.. The shortlisted applications will now be considered by the international panel acknowledging public/peer review comments and applicants’ right of reply. Results will be available in early July following HRB Board approval in June.
Investigator-led Clinical Trials (ILCT) Programme 2025 (formerly DIFA)
The Cycle 3 submission deadline was in December 2025. 57 applications were received. Eligibility checks are completed, with eligible applications moving to peer and public review. Following peer and public review applicants will be shortlisted and invited to submit a right of reply to peer/public review comments. The shortlisted applications will be considered by the international panel acknowledging public/peer review comments and applicants’ right of reply in October 2026. Results will be available in early December 2026 following HRB Board approval.
Investigator-Led Projects (ILP) 2026
The ILP scheme aims to support highly innovative and internationally competitive investigator-led projects that can respond to existing and emerging challenges for health and social care. The ILP provides funding for clearly defined research projects in: (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR).
Panel meetings took place during May and outcomes will be available subject to HRB board approval at the end of June 2026.
Research in-Practice Fellowships for Health and Social Care Practitioners (RPF) 2026
Peer and public review are currently underway for 32 eligible applications, with shortlisting envisaged in mid-June. The applicant response stage for a selected number of applications shortlisted to interview stage is scheduled for mid to late June. Interviews with an international panel will take place on 2 and 3 of September.
HRCI-HRB Joint Funding Scheme 2026
The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual HRCI-registered co-funding charity. 22 applications have been short-listed for panel review and the panel meeting will take place 26 and 27 May 2026.
Collaborative Postdoctoral Fellowships Programme (CPFP) 2026
Ten leadership teams invited to full applications stage are due to submit an application by 28 May. Peer and public review will start shortly after.
The “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)’ RITC call has two stages for applicants, both of which have now closed. Full proposals are currently under review with the rebuttal stage due to open at the end of June and overall outcome results expected in early September.
European Rare Diseases Research Alliance (ERDERA) Joint Transnational Call (JTC) 2026
‘Resolving unsolved cases in rare genetic and non-genetic diseases’ is the ERDERA JTC 2026 call topic. Pre-proposal submissions closed on 12 Feb 2026 and applicants have been informed of the peer review outcome with successful applicants invited to submit full proposals by 8 July 2026. Please ensure to submit required documentation to the HRB within the communicated timelines.
European Partnership on Transforming Health and Care Systems (THCS) 2026
Outcome emails for the pre-proposal stage have been issued. The deadline for applications invited to full proposal is 30 June 2026.
Conference and Event Sponsorship Scheme 2026
This scheme aims to create an opportunity to host health research related events, workshops, or conferences on the island of Ireland. Up to a maximum of €5,000 per grant is available. Cycle 2 will open on 9 June 2026.
Open Calls
The All-Ireland Cancer Consortium 2026 Scheme opened at 13:00 on 25 Feb 2026 and closes on 27 May 2026 at 13:00. An information webinar took place on 24 March at 14:00 and the recording is now available here.
The AICC 2026 call will target funding to support cancer research that focuses on survivorship, for people living well with and beyond a cancer diagnosis. Cancer survivorship research covers the period from diagnosis to treatment outcome and seeks to improve care and outcomes experienced by people living with and past cancer. It will enable support of cross-border cooperation and joint efforts in cancer survivorship research to ultimately benefit people, living across the island of Ireland and beyond.
The objectives of this scheme are:
- To stimulate, engage, develop, and improve all-island, multi-disciplinary cancer research collaborations, networking, and engagement
- Prime cancer research activity aligned to the Consortium’s priority areas with specific focus for 2026 to support ‘Survivorship-Living Well With & Beyond Cancer’
- Invest in high quality, innovative cancer research pilots, mapping activities, projects and/or education initiatives.
The overall goal of the scheme is to increase the level of collaboration and innovation amongst cancer researchers and experts across the jurisdictions of Ireland and Northern Ireland. As such we expect collaboration across the two jurisdictions to form a key component of the research proposal. All applicants will be required to have cross border collaborators as co-applicants to be deemed eligible to apply e.g., a Lead Applicant from Ireland requires a Co-Applicant from Northern Ireland and vice versa.
Inclusion of people with lived experience of cancer forms a central component, hence expectation is they’ll be involved throughout and part of application design and implementation.
The Applied Partnership Awards – Women’s Health (APA-WH) 2026
The Applied Partnership Awards Women’s Health (APA-WH) 2026 deadline for applications was 1 April 2026. Eligible proposals are currently under public and peer review. Update emails following the public and peer review stage are expected to be sent early July 2026.
US-Ireland Research and Development Partnership Programme
This is a rolling call. The call guidance has been updated and can be found here. Check the scheme notice for full details – US-Ireland R&D Partnership Programme.
Other European research funding opportunities
See our EU funding updates story for information on more European research funding opportunities.
See also general information on the Horizon Europe and EU4Health programmes.
